| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/26/2008 | CA2594906A1 Implantable medical device with annealed polymer coating |
| 01/25/2008 | CA2553402A1 Compositions for inhibiting sema7a and vla-1 interaction and methods of using the same |
| 01/24/2008 | WO2008011636A2 Targeted gene delivery for dendritic cell vaccination |
| 01/24/2008 | WO2008011621A2 Protein kinase c zeta inhibition to treat vascular permeability |
| 01/24/2008 | WO2008011611A2 Compounds and compositions as itpkb inhibitors |
| 01/24/2008 | WO2008011609A2 Compositions and methods for vaccinating against hsv-2 |
| 01/24/2008 | WO2008011588A2 Glycoconjugates of phosphoramidate alkylators for treatment of cancer |
| 01/24/2008 | WO2008011562A2 Composition having effect of treating, preventing, or improving diabetes or diabetic complication and drink comprising the same |
| 01/24/2008 | WO2008011559A2 Synthetic lung surfactant and use thereof |
| 01/24/2008 | WO2008011551A1 Morpholinyl and pyrrolidinyl analogs |
| 01/24/2008 | WO2008011539A2 Anesthetic compounds |
| 01/24/2008 | WO2008011538A2 Methods of using flavonoids to enhance memory |
| 01/24/2008 | WO2008011532A2 Treatment of pain with resiniferatoxin and related analogs |
| 01/24/2008 | WO2008011521A2 Polycyclic viral inhibitors |
| 01/24/2008 | WO2008011499A1 Synthesis of (2s,5r)-5-ethynyl-1-{n-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile |
| 01/24/2008 | WO2008011487A2 L-benzyl-l-hydr0xy-2, 3-diamin0-propyl amines and 3-benzyl-3-hydroxy-2-amino-propionicacid amides for chronic pain |
| 01/24/2008 | WO2008011485A2 Methods for treating chronic pain |
| 01/24/2008 | WO2008011484A2 Nicotinic desensitizers and methods of selecting, testing, and using them |
| 01/24/2008 | WO2008011478A2 Methods for treating chronic pain using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds |
| 01/24/2008 | WO2008011476A2 Compositions and methods for modulating sirtuin activity |
| 01/24/2008 | WO2008011462A2 Process for preparing solifenacin and its salts |
| 01/24/2008 | WO2008011426A2 Methods and medicaments for administration of ibuprofen |
| 01/24/2008 | WO2008011406A2 Carbonate and carbamate prodrugs of thiazolo [4,5-d] pyrimidines |
| 01/24/2008 | WO2008011364A2 Quercetin-containing compositions |
| 01/24/2008 | WO2008011363A2 Quercetin-containing compositions |
| 01/24/2008 | WO2008011337A1 Hcv inhibitors |
| 01/24/2008 | WO2008011216A2 Galactose-pronged polysaccharides in a formulation for antifibrotic therapies |
| 01/24/2008 | WO2008011190A1 Cgrp receptor antagonists |
| 01/24/2008 | WO2008011179A2 Omega-3 fatty acids for use in treating resistant hypertension |
| 01/24/2008 | WO2008011178A2 Compositions comprising omega-3 fatty acids, and their use in treating peripheral artery disease and intermittent claudication |
| 01/24/2008 | WO2008011177A2 Medicinal delivery system and related methods |
| 01/24/2008 | WO2008011176A2 Myosin light chain kinase inhibitor compounds, compositions and related methods of use |
| 01/24/2008 | WO2008011174A2 Jak inhibitors for treatment of myeloproliferative disorders |
| 01/24/2008 | WO2008011173A2 Improvement of arginase levels/activity |
| 01/24/2008 | WO2008011169A2 Controlled release formulations and associated methods |
| 01/24/2008 | WO2008011164A2 Methods and compositions for the treatment and prevention of infections |
| 01/24/2008 | WO2008011161A2 Dermal anesthetic compounds |
| 01/24/2008 | WO2008011154A2 Formulations for benzimidazolyl pyridyl ethers |
| 01/24/2008 | WO2008011150A1 Methods of improving the pharmacokinetics of doxepin |
| 01/24/2008 | WO2008011131A2 Amide compounds |
| 01/24/2008 | WO2008011130A2 Amide compounds |
| 01/24/2008 | WO2008011126A2 Liquid compositions of calcium acetate |
| 01/24/2008 | WO2008011113A2 Thiadiazolidinone derivatives |
| 01/24/2008 | WO2008011110A2 Di-amino-substituted heterocyclic compounds and methods of use |
| 01/24/2008 | WO2008011109A2 Substituted pyridone compounds and methods of use |
| 01/24/2008 | WO2008011100A2 Regional cardiac tissue treatment |
| 01/24/2008 | WO2008011087A2 Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease |
| 01/24/2008 | WO2008011085A1 Compositions and methods for the treatment of mucositis |
| 01/24/2008 | WO2008011083A2 Compounds for enhancing arginase activity and methods of use thereof |
| 01/24/2008 | WO2008011074A2 Histone deacetylase inhibitors |
| 01/24/2008 | WO2008011073A2 Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof |
| 01/24/2008 | WO2008011072A2 Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof |
| 01/24/2008 | WO2008011071A2 Interactions of hedgehog and liver x receptor signaling pathways |
| 01/24/2008 | WO2008011045A2 3-ARYL-6-ARYL-7H-[1,2,4]TRIAZOLO[3,4-b][1,3,4]THIADIAZINES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF |
| 01/24/2008 | WO2008011032A1 Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors |
| 01/24/2008 | WO2008011016A2 Treating gastroesophageal reflux disease with 5-ht3- and gaba receptor agonists |
| 01/24/2008 | WO2008011007A2 Selective antagonists of a2a adenosine receptors |
| 01/24/2008 | WO2008011005A2 Antiangiogenic agents |
| 01/24/2008 | WO2008010985A2 Phosphorus derivatives as histone deacetylase inhibitors |
| 01/24/2008 | WO2008010984A2 Acridine activation of p53 and uses thereof |
| 01/24/2008 | WO2008010963A2 Immune response modifier formulations |
| 01/24/2008 | WO2008010953A2 Pyridinone diketo acids: inhibitors of hiv replication in combination therapy |
| 01/24/2008 | WO2008010921A2 Modulators of pharmacokinetic properties of therapeutics |
| 01/24/2008 | WO2008010811A1 Methods and compositions for inducing protective responses to antigenic toxins |
| 01/24/2008 | WO2008010800A1 Par-4 related methods and compositions |
| 01/24/2008 | WO2008010794A1 Pharmaceutical preparations of crystalline lazabemide |
| 01/24/2008 | WO2008010776A1 Aigialomycin d and derivatives thereof and their use in treating cancer or malaria or a microbial infection |
| 01/24/2008 | WO2008010768A1 Method of treating and diagnosing restless legs syndrome and periodic limb movements during sleep and means for carrying out the method |
| 01/24/2008 | WO2008010765A1 Novel tricyclic spiropiperidine compounds, their synthesis and their uses as modulators of chemokine receptor activity |
| 01/24/2008 | WO2008010697A1 Curcumin-based drug for the treatment of parasitic infection caused by giardia lamblia |
| 01/24/2008 | WO2008010668A1 20(s -ginsenoside rg3 as an anti-angiogenic composition |
| 01/24/2008 | WO2008010663A1 Sophoricoside-containing composition for reducing body-weight or body-fat |
| 01/24/2008 | WO2008010601A1 NF- ϰB INHIBITOR |
| 01/24/2008 | WO2008010571A1 2'-cyanopyrimidine nucleoside compound |
| 01/24/2008 | WO2008010567A1 Salt or solvate of 5-methyl-2-(piperazin-1-yl)benzenesulfonic acid |
| 01/24/2008 | WO2008010566A1 Crystalline polymorphism of 5-methyl-2-(piperazin-1-yl)benzenesulfonic acid |
| 01/24/2008 | WO2008010527A1 Composition for amelioration of defecation |
| 01/24/2008 | WO2008010511A1 Screening method |
| 01/24/2008 | WO2008010481A1 Aminoindan derivative or salt thereof |
| 01/24/2008 | WO2008010472A1 Total enteral nutrition composition |
| 01/24/2008 | WO2008010448A1 Novel crystal of substituted phenylalkanoic acid and production process |
| 01/24/2008 | WO2008010428A1 Immunomodulating agent |
| 01/24/2008 | WO2008010403A1 Method for preventing coloration of catechins and dentifrice composition |
| 01/24/2008 | WO2008010362A1 Powder of vitamin e/proline complex and method of producing the same |
| 01/24/2008 | WO2008010335A1 Plant extract having arthritis-preventive effect |
| 01/24/2008 | WO2008010324A1 12-deoxyfusicoccin derivative and cell differentiation-inducing agent containing the same as active ingredient |
| 01/24/2008 | WO2008010315A1 Therapeutic agent for amyotrophic lateral sclerosis |
| 01/24/2008 | WO2008010241A1 A liposomal complex of sodium carboxymethyl beta-glucan |
| 01/24/2008 | WO2008010238A2 Antidiabetic azabicyclo [3. 1. 0] hexan compounds |
| 01/24/2008 | WO2008010225A2 Enhancement of regulatory t cells' activity using statins |
| 01/24/2008 | WO2008010087A2 Polymorphic forms of an hmg-coa reductase inhibitor and uses thereof |
| 01/24/2008 | WO2008010073A1 Tartrate salt of (7s)-7-[(5-fluoro-2-methyl-benzyl)oxy]-2-[(2r)-2-methylpiperazin-1-yl]-6,7-dihydro-5h-cyclopenta[b]pyridine |
| 01/24/2008 | WO2008010008A2 Cardiovascular combinations using rennin-angiotensin inhibitors |
| 01/24/2008 | WO2008009963A2 Pyrimidine derivatives as modulators of parathyroid hormone receptors |
| 01/24/2008 | WO2008009954A1 Medical use of cyclin dependent kinases inhibitors |
| 01/24/2008 | WO2008009935A1 Pharmaceutical compositions and their use |
| 01/24/2008 | WO2008009927A1 Use of fulvestrant and an aromatase inhibitor for treating breast cancer |
| 01/24/2008 | WO2008009924A2 Indoles useful in the treatment of inflammation |
| 01/24/2008 | WO2008009909A1 Pteridimones as modulators of polo-like kinase |
| 01/24/2008 | WO2008009894A2 Use of imino sugars in immunotherapy |